Clostridioides difficile infection in hospitalized children and adolescents

Published On: 18 Mar, 2023 2:47 PM | Updated On: 15 May, 2024 4:45 PM

Clostridioides difficile infection in hospitalized children and adolescents

Edwards et al., in their recent study, examined a 42-hospital Pediatric Health Information System (PHIS) administrative database to revise prior studies on the incidence and circumstances of Clostridioides difficile infections (CDI), use of diagnostic tests, and management of infections. They analyzed >23000 cases of CDI in hospitalized children from 2013 – 2019. Reversing a trend of bygone decades, they discovered a decline in hospitalized cases of CDI over the study period, from 7.09 cases/10000 patient days in 2013 to 4.89 cases/10000 patient days in 2019. They also found a decrease in C difficile-specific testing and an increase in the use of GI panel PCR testing. As earlier, >80% of patients with CDI displayed the presence of an underlying condition, with one-third each with chronic GI conditions or malignancy. Although metronidazole remained the most popular therapy choice, its use fell, contrasting to oral vancomycin.

There might be a true decline in CDI incidence in hospitalized pediatric patients due to improved cleaning and infection control practices and the more judicious use of antibiotics, yet there are many other factors too that could direct only an apparent change, most notably the modifications via guidelines to minimize by pre-test selection to a smaller number of patients being tested, and employing a stepwise testing scheme that would reduce detection of colonized-only individuals. 

More precise observation over the next decade will render detailed data on the inpatient burden of CDI and the effectiveness of the measure we take daily, such as handwashing, cleaning, and control of prescribing unnecessary antibiotics, to reduce the occurrence and spread of cases further.

Long SS. Contemporary observations on clostridioides difficile infection in hospitalized children and adolescents. The Journal of Pediatrics. 2023;252:1-2. DOI:https://doi.org/10.1016/j.jpeds.2022.11.017

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks